Syndax Pharmaceuticals (1T3.F) Q1 2026 Earnings

26FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.11
-0.9
-0.7
-0.49

Details

Expected EPS
-0.49487131475999996
Actual EPS
-0.6609096
Surprise EPS
-0.17
Surprise Percent
+33.55%

Description

Syndax Pharmaceuticals (1T3.F) has reported earnings of -0.6609096 per share for Q1 2026.

0 Comments

Share your thoughts